HEAL Biomarker Webinar

The HEAL Biomarker Program is dedicated to advancing biomarkers for pain conditions. The program is focused on supporting research to promote biomarkers that will improve the quality and efficiency of Phase II clinical trials and clinical practice. The HEAL Biomarker Program provides support for biomarker and endpoint discovery, along with analytical and clinical validation in a manner that is consistent with FDA guidelines.

An interactive Q&A webinar was held for interested applicants. All investigators interested in learning about the HEAL Biomarker funding opportunities are encouraged to participate and find information about the current open funding opportunity.

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) (nih.gov) RFA-NS-22-050.

Receipt dates for this HEAL Biomarker Funding Opportunity are March 11, 2022, June 23, 2022, and October 13, 2022.

Moderator

Dr. Ram Arudchandran, Program Director, HEAL/Pain Biomarker

For More Information, Contact:

You can also submit questions to Dr. Ram Arudchandran.